Mesothelioma Drug Slows Disease Progression in Patients With an Inactive NF2 Gene, South Paris University Study  
11/9/2012 7:35:12 AM

Preliminary findings from the first trial of a new drug for patients with mesothelioma show that it has some success in preventing the spread of the deadly disease in patients lacking an active tumour suppressor gene called NF2. The study is presented at the 24th EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Dublin, Ireland, November 9 [2].